REGN1033
Sponsors
Regeneron Pharmaceuticals
Conditions
HealthyHealthy Volunteers
Phase 1
Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects
CompletedNCT02741739
Start: 2016-03-31End: 2016-05-31Updated: 2016-10-14
Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men
CompletedNCT02943239
Start: 2016-12-08End: 2019-04-30Updated: 2024-08-09